Pan-tumor MRD Study
Part of paid clinical trials in San Diego, California.
- Sponsor
- Paradigm Health
- Study ID
- NCT06605404
- Status
- Recruiting
Conditions
- Esophageal Cancer
- Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
- Melanoma (Skin Cancer)
- Mix of Solid Tumors (MOST)
- Muscle Invasive Bladder Urothelial Carcinoma
- NSCLC (Non-small Cell Lung Cancer)
- Pancreatic (Exocrine Only)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- blood and tissue samples — DIAGNOSTIC_TESTroutine standard of care
- blood and tissue samples — OTHERRoutine standard of care
Study Details
The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors. The information collected will be used to develop tests to better understand cancer, for example, to improve cancer detection and to assess the risk of cancer coming back. Participants will receive routine standard of care from their doctor and their involvement is expected to last for approximately five and a half (5.5) years.
Key Dates
- Start date
- Jan 8, 2025
- Status verified
- Aug 2025
- Primary completion
- Dec 31, 2031
- Completion
- Apr 30, 2032
Study Design
- Enrollment
- 1,350 participants (estimated)
Arms
- Arm: Muscle Invasive Urothelial Carcinoma of the Bladder (MIBC)Muscle Invasive Urothelial Carcinoma of the Bladder (MIBC)
- Arm: EsophagealEsophageal cancer
- Arm: Gastric and Gastroesophageal Junction (GEJ)Gastric and Gastroesophageal Junction (GEJ)
- Arm: MelanomaMelanoma
- Arm: Non-small cell lung (NSCLC)Non-small cell lung (NSCLC)
- Arm: Pancreatic (exocrine only)Pancreatic (exocrine only)
- Arm: Mix of Solid Tumors (MOST)Mix of Solid Tumors (MOST)
Primary Outcome Measure
Blood and tissue biospecimen registry [ Time Frame: Observation from enrollment to 5.5 years after enrollment ]
Central Contacts
- Anosheh Afghahi, MD888-662-6367
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical Oncology Associates of San Diego | San Diego | California | 92123 | Alexis Bustamante |
| Taylor Cancer Research Center | Maumee | Ohio | 43437 |
Find similar trials in San Diego, CA
By condition
By specialty
Related Studies
- Clinical & Pathological Studies of Upper Gastrointestinal CarcinomaRecruiting · Stanford University · Stanford, California
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)Recruiting · University of Colorado, Denver · Los Angeles, California
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California